Physician

Thomas A Haldis, DO

According to 2025 Medicare claims, Thomas Haldis, DO (NPI: 1588681449) practices interventional cardiology in the Fargo, ND-MN market, with the plurality of this provider's patient population coming from Cass, ND. This provider's primary affiliated billing organization is SANFORD MEDICAL CENTER FARGO (NPI: 1184917924; TIN: 450226909) and primary practice location at 58104-7927. Haldis is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Haldis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 634 traditional Medicare patients, billed 2,038 HCPCS/CPT codes, and received $240,588 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,040 prescription claims across 259 beneficiaries totaling $114,598 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 55 records totaling $153,686. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $45,604 to $114,598. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	684	2,336	$233,726
2016	594	2,173	$256,832
2017	706	2,135	$228,112
2018	665	2,358	$249,484
2019	1,059	4,288	$431,003
2020	1,057	3,982	$432,038
2021	943	3,141	$315,820
2022	956	3,024	$347,895
2023	807	2,411	$283,771
2024	634	2,038	$240,588

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	276	1,118	$45,604
2016	332	1,628	$81,478
2017	227	942	$48,088
2018	236	888	$51,719
2019	344	1,438	$82,797
2020	405	1,492	$88,652
2021	345	1,275	$76,680
2022	297	1,180	$71,153
2023	325	1,178	$100,786
2024	259	1,040	$114,598

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	118	118	$122
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	102	109	$95
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	265	299	$49
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	143	148	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	210	306	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	91	4,117	$75,414
Brilinta	Ticagrelor	18	780	$11,761
Enoxaparin Sodium	Enoxaparin Sodium	22	91	$1,693
Warfarin Sodium	Warfarin Sodium	198	3,833	$1,425
Jantoven	Warfarin Sodium	127	2,594	$1,131

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$3,061	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	11	$150,625	Edwards Lifesciences Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas A. Haldis, DO?

Tedicare shows public-source Medicare data for Thomas A. Haldis, DO (NPI 1588681449), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas A. Haldis, DO have ACO affiliation data?

Thomas A. Haldis, DO is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Thomas A. Haldis, DO?

Thomas A. Haldis, DO is linked to SANFORD MEDICAL CENTER FARGO (billing NPI 1184917924) in the available physician profile data.

Does Thomas A. Haldis, DO have Open Payments data?

Thomas A. Haldis, DO has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.